EHA 2022 Conference Coverage
EHA 2022 Tamibarotene in Combination With Ven & Aza in Previously Untreated Adult Pts Selected for RARA+ AML Who Are Ineligible for Standard Induction Therapy (SELECT-AML-1)
By
EHA 2022 Conference Coverage
FEATURING
Eytan Stein
By
EHA 2022 Conference Coverage
FEATURING
Eytan Stein
Comments 0
Login to view comments.
Click here to Login